drugset / Trial / NCT01468415

Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs

NCT01468415

Phase 1 Unknown 60 enrolled Assaf-Harofeh Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The American Society of Anesthesiologists Task Force on Management, Chronic Pain section, recommended Phenol neurolysis when other techniques have failed to provide adequate pain control. In this study we sought to Compare the pain relieve on a Lower Back and Limbs obtained from Methylprednisolone and Phenol 8% Treatment given by Trans Sacral Approach. The study includes patients who suffers from a chronic low back and/or limbs pain which were referred to be given epidural as a treatment. Control group receives 80 mg Methylprednisolone while the test group receives phenol 8%.

Timeline

Start
2011-06
Primary completion
2013-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 80 mg Other
Subject Phenol Other / unclassified 8 % Other
Background Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.